Litcius/Paper detail

Development of Triple-Negative Breast Cancer-Targeted Liposomes with MUC16 Binding Peptide Ligand in Triple-Negative Breast Cancer Cells

Masayori Hagimori, Naoya Kato, Akira Orimoto, Tadaharu Suga, Shigeru Kawakami

2023Journal of Pharmaceutical Sciences23 citationsDOI

Topics & Concepts

Triple-negative breast cancerCancer researchBreast cancerEstrogen receptorTargeted therapyProgesterone receptorLiposomeChemistryCancerMedicineInternal medicineBiochemistryGlycosylation and Glycoproteins ResearchMonoclonal and Polyclonal Antibodies ResearchImmunotherapy and Immune Responses
Development of Triple-Negative Breast Cancer-Targeted Liposomes with MUC16 Binding Peptide Ligand in Triple-Negative Breast Cancer Cells | Litcius